Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate
(23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate (217)
- Fusion and Fission Energy and Science Directorate (21)
- Information Technology Services Directorate (2)
- Isotope Science and Enrichment Directorate (6)
- National Security Sciences Directorate (17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (128)
- User Facilities (27)
Researcher
- Chad Steed
- Junghoon Chae
- Mingyan Li
- Sam Hollifield
- Travis Humble
- Brian Sanders
- Brian Weber
- Bruce Moyer
- Debjani Pal
- Gerald Tuskan
- Ilenne Del Valle Kessra
- Isaac Sikkema
- Jeffrey Einkauf
- Jennifer M Pyles
- Jerry Parks
- Joseph Olatt
- Kevin Spakes
- Kunal Mondal
- Kuntal De
- Laetitia H Delmau
- Lilian V Swann
- Luke Koch
- Luke Sadergaski
- Mahim Mathur
- Mary A Adkisson
- Oscar Martinez
- Paul Abraham
- Samudra Dasgupta
- T Oesch
- Vilmos Kertesz
- Xiaohan Yang
- Yang Liu

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

The QVis Quantum Device Circuit Optimization Module gives users the ability to map a circuit to a specific quantum devices based on the device specifications.

QVis is a visual analytics tool that helps uncover temporal and multivariate variations in noise properties of quantum devices.

Detection of gene expression in plants is critical for understanding the molecular basis of plant physiology and plant responses to drought, stress, climate change, microbes, insects and other factors.

Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

Real-time tracking and monitoring of radioactive/nuclear materials during transportation is a critical need to ensure safety and security. Current technologies rely on simple tagging, using sensors attached to transport containers, but they have limitations.

There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).